Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
作者信息
Skander D, Allenova A, Maurer M, Kolkhir P
机构信息
Division of Immune-mediated skin diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
出版信息
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
Abstract
摘要
Zotero 插件